|
Exposure
|
Study groups
| | |
|---|
|
Serumb
|
Infections
|
White blood cells
|
Lymphocyte subsets
|
|---|
|
CB 28+52+101
|
4 (3–427)
|
4 (3–427)
|
4 (3–19)
|
|
CB-153
|
60 (23–179)
|
57 (23–158)
|
59 (23–158)
|
|
Di-ortho PCB
|
131 (44–362)
|
127 (44–342)
|
129 (44–342)
|
|
Mono-ortho PCB TEQ
|
4 (1–20)
|
4 (1–11)
|
4 (1–9)
|
|
p,p'-DDE
|
88 (21–622)
|
85 (24–622)
|
83 (29–622)
|
|
Mother's milk exposurec
| | | |
|
CB 28+52+101
|
8 (0–155)
|
8 (0–76)
|
9 (0–39)
|
|
CB-153
|
187 (0–853)
|
174 (0–396)
|
186 (0–396)
|
|
Di-ortho PCB
|
364 (0–1666)
|
351 (0–830)
|
372 (0–830)
|
|
Mono-ortho PCB TEQ
|
11 (0–54)
|
11 (0–26)
|
11 (0–26)
|
|
p,p'-DDE
|
311 (0–2199)
|
289 (0–2199)
|
306 (0–2199)
|
-
aMedian (range). Di-ortho PCB = CB-138, CB-153, CB-180; Mono-ortho PCB TEQ = CB-105, CB-118, CB-156, CB-167 [32]. The study group "Infections" consists of all study participants (prenatal exposure N = 190; postnatal exposure N = 175), the "White blood cells" group is a subgroup of infants among the study participants which had their WBC counts analyzed (N = 86), and within this subgroup lymphocyte subsets were analyzed in the "Lymphocyte" group composed of infants with enough blood left after WBC count analysis (N = 52).
-
bng/g lipid. Mono-ortho PCBs: pg TEQ/g lipid [32]. Serum sampled week 32–34.
-
cng/g fresh weight*days. Mono-ortho PCBs: pg TEQ/g fresh weight*days. Calculated as organochlorine concentration in mother's milk on a fresh weight basis*days of nursing*(%of full nursing/100).
